Cleared Traditional

neuro42 MRI System (K232644) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K232644 · Neuro42, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2024
Decision
162d
Days
Class 2
Risk

K232644 is an FDA 510(k) clearance for the neuro42 MRI System. Classified as System, Nuclear Magnetic Resonance Imaging (product code LNH), Class II - Special Controls.

Submitted by Neuro42, Inc. (San Francisco, US). The FDA issued a Cleared decision on February 8, 2024 after a review of 162 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1000 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Neuro42, Inc. devices

Submission Details

510(k) Number K232644 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 30, 2023
Decision Date February 08, 2024
Days to Decision 162 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
55d slower than avg
Panel avg: 107d · This submission: 162d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LNH System, Nuclear Magnetic Resonance Imaging
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1000
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LNH System, Nuclear Magnetic Resonance Imaging

All 548
Devices cleared under the same product code (LNH) and FDA review panel - the closest regulatory comparables to K232644.
uMR Omega
K240540 · Shanghai United Imaging Healthcare Co., Ltd. · Mar 2024
MAGNETOM Cima.X Fit
K232765 · Siemens Medical Solutions USA, Inc. · Feb 2024
InVision™ 1.5 Surgical Theatre
K240157 · Deerfield Imaging, Inc. · Feb 2024
SIGNA Champion
K233728 · Ge Healthcare (Tianjin) Company Limited · Jan 2024
MAGNETOM Sola
K232535 · Siemens Medical Solutions USA, Inc. · Dec 2023
MAGNETOM Cima.X
K231587 · Siemens Medical Solutions USA, Inc. · Dec 2023